PPARG and hepatocellular carcinoma: The anticancer activity of hispidulin is due to its ability to inhibit the proliferation and metastasis of hepatocellular carcinoma (HCC) cells by activating PPAR-γ [176], suppressing allergic inflammatory reactions by reducing the release of histamine and inflammatory cytokines such as TNF-α and interleukin-4 [177].